期刊文献+

Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat

Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat
下载PDF
导出
摘要 The LTB of enterotoxigenic Escherichia coli (ETEC) expressed in Bifidobacterium infantis (BI) has been testified as mucosal adjuvant with co-vaccination BI-CfaB (the major fimbrial subunit) together in vivo in our previous study. In order to investigate the mucosal adjuvant effect of BI-LTB to purified antigens, we oral vaccinated SD rats with recombinant BI-LTB plus OVA (rBI-LTB + OVA), and wild type BI plus OVA (wBI + OVA), OVA and PBS (Phosphate buffered saline) were vaccinated as controls, respectively. The OVA-specific sIgA in jejunal mucosa and specific IgG in serium were measured with ELISA (Enzyme-linked immunosorbent assay) and the sIgA producing cells were detected with immunohistochemistry technology (IHC) and Qwin image manipulation tools subsequently. The results shown rBI-LTB could stimulate SD rats produce high titer OVA-specific sIgA in rBI-LTB + OVA group and the OVA-specific sIgA titer in rBI-LTB + OVA group was found significant greater than that of the wBI + OVA group or OVA single group (p < 0.05). However no such significant difference was detected between the group wBI + OVA and OVA. IHC results suggested that intestinal mucosa and submucosa was the main field of sIgA secretion. These results suggested that recombinant LTB expression in BI could be used as a wide range mucosal adjuvant with different form antigens. The LTB of enterotoxigenic Escherichia coli (ETEC) expressed in Bifidobacterium infantis (BI) has been testified as mucosal adjuvant with co-vaccination BI-CfaB (the major fimbrial subunit) together in vivo in our previous study. In order to investigate the mucosal adjuvant effect of BI-LTB to purified antigens, we oral vaccinated SD rats with recombinant BI-LTB plus OVA (rBI-LTB + OVA), and wild type BI plus OVA (wBI + OVA), OVA and PBS (Phosphate buffered saline) were vaccinated as controls, respectively. The OVA-specific sIgA in jejunal mucosa and specific IgG in serium were measured with ELISA (Enzyme-linked immunosorbent assay) and the sIgA producing cells were detected with immunohistochemistry technology (IHC) and Qwin image manipulation tools subsequently. The results shown rBI-LTB could stimulate SD rats produce high titer OVA-specific sIgA in rBI-LTB + OVA group and the OVA-specific sIgA titer in rBI-LTB + OVA group was found significant greater than that of the wBI + OVA group or OVA single group (p < 0.05). However no such significant difference was detected between the group wBI + OVA and OVA. IHC results suggested that intestinal mucosa and submucosa was the main field of sIgA secretion. These results suggested that recombinant LTB expression in BI could be used as a wide range mucosal adjuvant with different form antigens.
出处 《International Journal of Clinical Medicine》 2012年第5期387-393,共7页 临床医学国际期刊(英文)
关键词 BIFIDOBACTERIUM Infantis LTB OVA MUCOSAL Adjuvant Bifidobacterium Infantis LTB OVA Mucosal Adjuvant
  • 相关文献

参考文献1

二级参考文献10

  • 1李迎雪,杨林,王立生,荀安营,朱忠生,朱惠明.双歧杆菌的完整肽聚糖对巨噬细胞AP-1的影响[J].中国微生态学杂志,2007,19(2):129-131. 被引量:4
  • 2OUWEHAND A C. Antiallergic effects of probiotics[ J ]. J Nutr,2007, 137(3 Suppl 2) :794S-797S.
  • 3TAYLOR A L, DUNSTAN J A, PRESCOTT S L, et al. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial[ J]. J Allergy Clin Immunol, 2007,119 ( 1 ) : 184-191.
  • 4KADOWAKI N, et al. Dendritic cells : a conductor of T cell differentiation[ J ]. Allergol Int, 2007,56 ( 3 ) : 193-199.
  • 5DHODAPKAR K M, et al. Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells [ J ]. PNAS USA, 2005,102 (8) :2910-2915.
  • 6MACATONIA S E, HOSKEN N A, LITTON M,et al. Dendritic cells produce IL-12 and direct the development of Thl ceils from native CD4^+ T Cells[J]. J Immunol,1995,154(10) :5071-5079.
  • 7SAMARASINGHE R, TAILOR P,TAMURA T, et al. Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling [ J ]. J Interferon Cytokine Res, 2006, 26 ( 12 ) : 893 -900.
  • 8LANGENKAMP A, MESSI M, LANZAVECCHIA A. Kinetics of dendritic cell activation:impact on priming of Thl, Th2 and nonpolarized T cells[ J]. Nature Immunol,2000,1 (4) :311-316.
  • 9熊菲,程茜,刘明方,陈淑惠.双歧杆菌对单核细胞来源的树突状细胞成熟及功能影响的体外研究[J].四川大学学报(医学版),2007,38(5):783-787. 被引量:7
  • 10聂晶,程茜.双歧杆菌及其完整肽聚糖对脐血来源树突状细胞分泌IL-12的影响[J].中国微生态学杂志,2008,20(3):228-230. 被引量:3

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部